Dr. Chakraborty: Challenges of Quadruplet Therapy for Multiple Myeloma
By Rebecca Araujo - Last Updated: July 5, 2023DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on how new research on treatments for multiple myeloma may impact the treatment landscape, and challenges and opportunities from the paradigm shift from triplet to quadruplet therapy.
Advertisement
This is the second of a four-part conversation with Dr. Chakraborty. Watch part one, where Dr. Chakraborty discusses recent clinical trials for newly-diagnosed multiple myeloma.
Advertisement
Related Posts
Parkinson's disease and melanoma are believed to be linked due to DNA double-strand break repair thus cell proliferation.
Dr. Eric Dr. Bergson about the importance of head and neck cancer awareness, how to integrate screening into routine care.
AI analysis provides an opportunity for timely intervention to improve the ability to swallow as well as quality of life.
Euphorbis tirucalli leaf extract has the potential ability to inhibit EBV-positive cell proliferation.
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.